Description: Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 85.58 | 0.00 | 85.58 |
| Stock non-US | 14.49 | 0.00 | 14.49 |
| Cash | 0.94 | 1.01 | -0.07 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.78 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 87.85 | 90.74 |
| Europe Developed | 6.57 | 6.15 |
| Africa/Middle East | 3.97 | 0.10 |
| Japan | 1.62 | 0.50 |
| Australasia | 0.00 | 0.08 |
| Asia Emerging | 0.00 | 0.34 |
| Asia Developed | 0.00 | 0.03 |
| United Kingdom | 0.00 | 2.07 |